DEBORAH KING: Open Payments
NPI 1700227691 · MACKS CREEK, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $118 |
| Amgen Inc. | 3 | $47 |
| PFIZER INC. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Viatris Specialty LLC | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Abbott Laboratories | 1 | $25 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: CAPLYTA, REPATHA, YUPELRI, BREZTRI, PREVNAR 20, FREESTYLE LIBRE, ELIQUIS, JOURNAVX.
Industry payments across MO — which companies pay providers there.
